Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-27T18:20:49.625Z Has data issue: false hasContentIssue false

Population-based Toxoplasma seroprevalence study in The Netherlands

Published online by Cambridge University Press:  08 November 2004

L. M. KORTBEEK
Affiliation:
Diagnostic Laboratory for Infectious Diseases and Perinatal Screening, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands
H. E. De MELKER
Affiliation:
Department of Infectious Diseases Epidemiology, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands
I. K. VELDHUIJZEN
Affiliation:
Department of Infectious Diseases Epidemiology, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands
M. A. E. CONYN-VAN SPAENDONCK
Affiliation:
Department of Infectious Diseases Epidemiology, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

During 1995–1996 a population-based seroprevalence study was conducted in The Netherlands. Risk factors were established for postnatally acquired toxoplasmosis. The results were compared with a study conducted during 1987–1988 in pregnant women in the Southwest of The Netherlands in order to estimate the change in seroprevalence. In total, 7521 sera were tested and the national seroprevalence was 40·5% (95% CI 37·5–43·4). Living in the Northwest, having professional contact with animals, living in a moderately urbanized area, being divorced or widowed, being born outside The Netherlands, frequent gardening and owning a cat were independently associated with Toxoplasma seropositivity. Risk factors like eating undercooked meat could not be studied. The seroprevalence among women aged 15–49 years was 10% lower (35·2%, 95% CI 32·9–38·6) in the study of 1995–1996, compared to the Toxoplasma study of 1987–1988 (45·8%, 95% CI 45·2–46·3). The steepest rise in seroprevalence still occurred among the subjects aged 25–44 years.

Type
Research Article
Copyright
© 2004 Cambridge University Press